Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Jun 28;15(1):120.
doi: 10.1186/s12916-017-0871-z.

Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis

Affiliations
Meta-Analysis

Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis

James A Prior et al. BMC Med. .

Abstract

Background: Giant cell arteritis (GCA), if untreated, can lead to blindness and stroke. The study's objectives were to (1) determine a new evidence-based benchmark of the extent of diagnostic delay for GCA and (2) examine the role of GCA-specific characteristics on diagnostic delay.

Methods: Medical literature databases were searched from inception to November 2015. Articles were included if reporting a time-period of diagnostic delay between onset of GCA symptoms and diagnosis. Two reviewers assessed the quality of the final articles and extracted data from these. Random-effects meta-analysis was used to pool the mean time-period (95% confidence interval (CI)) between GCA symptom onset and diagnosis, and the delay observed for GCA-specific characteristics. Heterogeneity was assessed by I 2 and by 95% prediction interval (PI).

Results: Of 4128 articles initially identified, 16 provided data for meta-analysis. Mean diagnostic delay was 9.0 weeks (95% CI, 6.5 to 11.4) between symptom onset and GCA diagnosis (I 2 = 96.0%; P < 0.001; 95% PI, 0 to 19.2 weeks). Patients with a cranial presentation of GCA received a diagnosis after 7.7 (95% CI, 2.7 to 12.8) weeks (I 2 = 98.4%; P < 0.001; 95% PI, 0 to 27.6 weeks) and those with non-cranial GCA after 17.6 (95% CI, 9.7 to 25.5) weeks (I 2 = 96.6%; P < 0.001; 95% PI, 0 to 46.1 weeks).

Conclusions: The mean delay from symptom onset to GCA diagnosis was 9 weeks, or longer when cranial symptoms were absent. Our research provides an evidence-based benchmark for diagnostic delay of GCA and supports the need for improved public awareness and fast-track diagnostic pathways.

Keywords: Diagnostic delay; Giant cell arteritis; Meta-analysis; Systematic review.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Selection of articles for inclusion in systematic review and meta-analysis
Fig. 2
Fig. 2
Meta-analysis of time-periods of delay in receiving a diagnosis of giant cell arteritis
Fig. 3
Fig. 3
Meta-analysis comparing delay in diagnosis between GCA with cranial or non-cranial characteristics

References

    1. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis. 2006;65(8):1093–8. doi: 10.1136/ard.2005.046912. - DOI - PMC - PubMed
    1. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509–20. doi: 10.1016/S0002-9394(99)80192-5. - DOI - PubMed
    1. Barraclough K, Mallen CD, Helliwell T, Hider SL, Dasgupta B. Diagnosis and management of giant cell arteritis. Br J Gen Pract. 2012;62(599):329–30. doi: 10.3399/bjgp12X649313. - DOI - PMC - PubMed
    1. Ponte C, Rodrigues AF, O’Neill L, Luqmani RA. Giant cell arteritis: Current treatment and management. World J Clin Cases. 2015;3(6):484–94. - PMC - PubMed
    1. Smith JH, Swanson JW. Giant cell arteritis. Headache. 2014;54(8):1273–89. doi: 10.1111/head.12425. - DOI - PubMed